Votrient 新西兰 - 英文 - Medsafe (Medicines Safety Authority)

votrient

novartis new zealand ltd - pazopanib hydrochloride 433.4mg equivalent to 400 mg pazopanib base;  ;   - film coated tablet - 400 mg - active: pazopanib hydrochloride 433.4mg equivalent to 400 mg pazopanib base     excipient: magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g povidone sodium starch glycolate - votrient is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (rcc).

Votrient 400mg tablets 英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

votrient 400mg tablets

novartis pharmaceuticals uk ltd - pazopanib hydrochloride - tablet - 400mg

Votrient 200mg tablets 英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

votrient 200mg tablets

novartis pharmaceuticals uk ltd - pazopanib hydrochloride - tablet - 200mg

Votrient 200mg Film-Coated Tablet 肯尼亚 - 英文 - Pharmacy and Poisons Board

votrient 200mg film-coated tablet

nvs kenya limited p.o box 46057-00100 gpo nairobi - pazopanib - film-coated tablet - 200mg - pazopanib